X0306 4 2019-08-02 0 0001660334 Verrica Pharmaceuticals Inc. VRCA 0001741937 Davidson Matt C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380 0 0 1 0 Common Stock 2019-08-02 4 S 0 1969 10.78 D 2588775 D Common Stock 2019-08-05 4 S 0 1679 10.65 D 2587096 D Common Stock 2019-08-06 4 S 0 2602 10.28 D 2584494 D These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 22, 2018. The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.25 to $11.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.28 to $10.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Mark Ballantyne, Attorney-in-Fact 2019-08-06